TP53 and cancer: For patients with higher expression of ANO1, TMEM156, and TMEM173 the changes in the groups of genes (with NES between 1.642 and 2.469) which were similar to these induced by modification in the expression levels of important proto-oncogenes and suppressors such as MYC, KRAS, CyclinD1, and P53 or genes associated with EMT process or maintaining of the cancer-initiating cells (CICs) population were indicated.